Terms: = Prostate cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Diagnosis
5 results:
1. erbb3 Overexpression is Enriched in Diverse Patient Populations with Castration-sensitive prostate cancer and is Associated with a Unique AR Activity Signature.
Vellky JE; Kirkpatrick BJ; Gutgesell LC; Morales M; Brown RM; Wu Y; Maienschein-Cline M; Notardonato LD; Weinfeld MS; Nguyen RH; Brister E; Sverdlov M; Liu L; Xu Z; Kregel S; Nonn L; Vander Griend DJ; Reizine NM
Clin Cancer Res; 2024 Apr; 30(8):1530-1543. PubMed ID: 38306015
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study.
Avolio PP; Fasulo V; Sanchez-Salas R; Maffei D; Frego N; Lazzeri M; Paciotti M; Saita A; Hurle R; Guazzoni G; Casale P; Buffi NM; Lughezzani G
World J Urol; 2023 Sep; 41(9):2335-2342. PubMed ID: 37418017
[TBL] [Abstract] [Full Text] [Related]
3. Treatment characteristics for nonmetastatic castration-resistant prostate cancer in the United States, Europe and Japan.
Shah R; Botteman M; Waldeck R
Future Oncol; 2019 Dec; 15(35):4069-4081. PubMed ID: 31687847
[No Abstract] [Full Text] [Related]
4. Increasing the number of biopsy cores improves the concordance of biopsy Gleason score to prostatectomy Gleason score.
Coogan CL; Latchamsetty KC; Greenfield J; Corman JM; Lynch B; Porter CR
BJU Int; 2005 Aug; 96(3):324-7. PubMed ID: 16042723
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of biomarker modulation by fenretinide in prostate cancer patients.
Urban D; Myers R; Manne U; Weiss H; Mohler J; Perkins D; Markiewicz M; Lieberman R; Kelloff G; Marshall M; Grizzle W
Eur Urol; 1999; 35(5-6):429-38. PubMed ID: 10325501
[TBL] [Abstract] [Full Text] [Related]
